John P. Schmid

Insider Reports History

Entity
Individual
Location
6310 Nancy Ridge Drive, Suite 101, San Diego, California
Signature
/s/ Beth Hecht, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John P. Schmid:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 113K $254K $2.25 Aug 12, 2024 Direct
Poseida Therapeutics, Inc. Director Common Stock 59K $243K $4.13 Jun 17, 2024 Direct
Design Therapeutics, Inc. Director Common Stock 30.7K $115K $3.74 Mar 22, 2024 Direct
Design Therapeutics, Inc. Director Common Stock 27K $101K $3.74 Mar 25, 2024 By Schmid Family Trust U/A dated 8-15-17
ANAPTYSBIO, INC Director Common Stock 3.9K $90.3K $23.16 Jun 15, 2024 Direct
Xeris Biopharma Holdings, Inc. Director Common Stock 25.2K $56.6K $2.25 Aug 12, 2024 By: The Schmid Family Trust dated August 15, 2017
ANAPTYSBIO, INC Director Restricted Stock Unit 0 $0 $23.16 Jun 15, 2024 Direct
Poseida Therapeutics, Inc. Director Stock Option (Right to buy) 27.4K Jun 17, 2024 Direct
Design Therapeutics, Inc. Director Stock Option (right to buy) 19K Jun 13, 2024 Direct
ANAPTYSBIO, INC Director Stock Option (right to buy) 16.5K Jan 3, 2024 Direct
XERIS PHARMACEUTICALS INC Director Common Stock 0 Oct 5, 2021 Direct
XERIS PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 Oct 5, 2021 Direct

Insider Reports Filed by John P. Schmid

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XERS Xeris Biopharma Holdings, Inc. Aug 12, 2024 1 $10.1K 4 Aug 13, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Aug 9, 2024 1 $10.1K 4 Aug 12, 2024 Director
PSTX Poseida Therapeutics, Inc. Jun 17, 2024 2 $0 4 Jun 18, 2024 Director
ANAB ANAPTYSBIO, INC Jun 15, 2024 2 $0 4 Jun 18, 2024 Director
DSGN Design Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
XERS Xeris Biopharma Holdings, Inc. May 10, 2024 1 $10.3K 4 May 10, 2024 Director
DSGN Design Therapeutics, Inc. Mar 22, 2024 2 $99.7K 4 Mar 25, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Mar 14, 2024 1 $9.72K 4 Mar 14, 2024 Director
HLXB Helix Acquisition Corp. II Feb 8, 2024 0 $0 3 Feb 9, 2024 Director
ANAB ANAPTYSBIO, INC Jan 3, 2024 2 $0 4 Jan 5, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Nov 16, 2023 1 $9.82K 4 Nov 17, 2023 Director
PSTX Poseida Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
XERS Xeris Biopharma Holdings, Inc. Jun 7, 2023 1 $0 4 Jun 7, 2023 Director
DSGN Design Therapeutics, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
ANAB ANAPTYSBIO, INC Jan 6, 2023 2 $0 4 Jan 10, 2023 Director
PSTX Poseida Therapeutics, Inc. Jun 16, 2022 2 $0 4 Jun 16, 2022 Director
DSGN Design Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
XERS Xeris Biopharma Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
ANAB ANAPTYSBIO, INC Feb 10, 2022 1 $0 4 Feb 14, 2022 Director
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 5 $0 4 Oct 5, 2021 Director
XERS XERIS PHARMACEUTICALS INC Oct 5, 2021 5 $0 4 Oct 5, 2021 Director
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
PSTX Poseida Therapeutics, Inc. Jul 23, 2021 1 $0 4 Jul 26, 2021 Director
PSTX Poseida Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
XERS XERIS PHARMACEUTICALS INC Jun 8, 2021 1 $0 4 Jun 8, 2021 Director